Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Home
/
About the Reporter
/
Park Pyeongtak
Park Pyeongtak
Reporter
Biowatch Team
With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail
ppt@kormedi.com
Latest Articles
Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
6/17/2026
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
6/17/2026
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
6/15/2026
GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques
6/11/2026
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial
6/11/2026
FDA Grants Streamlined Path for MediPost’s Cartistem, Slashing U.S. Trial Burden
6/8/2026
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
6/5/2026
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
6/4/2026
Previous
8
9
10
11
12
Next